000 | 01453 a2200445 4500 | ||
---|---|---|---|
005 | 20250513045727.0 | ||
264 | 0 | _c19950316 | |
008 | 199503s 0 0 eng d | ||
022 | _a0004-4172 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClemente, E | |
245 | 0 | 0 |
_aTherapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children. _h[electronic resource] |
260 |
_bArzneimittel-Forschung _cDec 1994 |
||
300 |
_a1490-4 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aAnti-Infective Agents, Urinary _xtherapeutic use |
650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhagocytosis _xdrug effects |
650 | 0 | 4 |
_aPyrrolidonecarboxylic Acid _xadverse effects |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 |
_aThiazoles _xadverse effects |
650 | 0 | 4 | _aThiazolidines |
650 | 0 | 4 |
_aUrinary Tract Infections _xdrug therapy |
700 | 1 | _aSolli, R | |
700 | 1 | _aMei, V | |
700 | 1 | _aCera, R | |
700 | 1 | _aCaramia, G | |
700 | 1 | _aCarnelli, V | |
700 | 1 | _aRuffini, E | |
700 | 1 | _aVenturoli, V | |
700 | 1 | _aCorsini, A | |
773 | 0 |
_tArzneimittel-Forschung _gvol. 44 _gno. 12A _gp. 1490-4 |
|
999 |
_c7856685 _d7856685 |